Yanling Chen, Zhoumiao Qi, Chaoyue Hu, Yanling Yu, Kai Liu
{"title":"转移性舌鳞状细胞癌患者的预后图:一项基于seer的研究。","authors":"Yanling Chen, Zhoumiao Qi, Chaoyue Hu, Yanling Yu, Kai Liu","doi":"10.1111/odi.15381","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To construct and validate a predictive nomogram for patients with metastatic tongue squamous cell carcinoma (MTSCC).</p><p><strong>Methods: </strong>From 2010 to 2015, the SEER database was used to gather the clinical information of MTSCC patients. R software was used to establish a nomogram to predict the cancer-specific survival (CSS) probability of MTSCC patients. The nomogram was validated by the concordance index (C-index), the area under the receiver-operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).</p><p><strong>Results: </strong>Following screening, 284 patients were randomized, with 199 people placed in the training cohort and 85 people placed in the validation cohort, at a ratio of 7:3. By using multivariate Cox regression analysis, it was discovered that chemotherapy, lymph node dissection, brain, bone, lung metastases, and N stage were independent risk factors for CSS. The C-index was 0.664 in the training group and 0.683 in the validation group. The AUC of 1-, 3-, and 5-year CSS rates was more than 0.71, and the calibration plot further demonstrated the nomogram's strong validity. DCA showed that the nomogram had good clinical significance.</p><p><strong>Conclusion: </strong>The CSS probability of patients with MTSCC can be reliably and intuitively predicted by the established nomogram model.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prognostic Nomogram for Patients With Metastatic Tongue Squamous Cell Carcinoma: A SEER-Based Study.\",\"authors\":\"Yanling Chen, Zhoumiao Qi, Chaoyue Hu, Yanling Yu, Kai Liu\",\"doi\":\"10.1111/odi.15381\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To construct and validate a predictive nomogram for patients with metastatic tongue squamous cell carcinoma (MTSCC).</p><p><strong>Methods: </strong>From 2010 to 2015, the SEER database was used to gather the clinical information of MTSCC patients. R software was used to establish a nomogram to predict the cancer-specific survival (CSS) probability of MTSCC patients. The nomogram was validated by the concordance index (C-index), the area under the receiver-operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).</p><p><strong>Results: </strong>Following screening, 284 patients were randomized, with 199 people placed in the training cohort and 85 people placed in the validation cohort, at a ratio of 7:3. By using multivariate Cox regression analysis, it was discovered that chemotherapy, lymph node dissection, brain, bone, lung metastases, and N stage were independent risk factors for CSS. The C-index was 0.664 in the training group and 0.683 in the validation group. The AUC of 1-, 3-, and 5-year CSS rates was more than 0.71, and the calibration plot further demonstrated the nomogram's strong validity. DCA showed that the nomogram had good clinical significance.</p><p><strong>Conclusion: </strong>The CSS probability of patients with MTSCC can be reliably and intuitively predicted by the established nomogram model.</p>\",\"PeriodicalId\":19615,\"journal\":{\"name\":\"Oral diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/odi.15381\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/odi.15381","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Prognostic Nomogram for Patients With Metastatic Tongue Squamous Cell Carcinoma: A SEER-Based Study.
Objective: To construct and validate a predictive nomogram for patients with metastatic tongue squamous cell carcinoma (MTSCC).
Methods: From 2010 to 2015, the SEER database was used to gather the clinical information of MTSCC patients. R software was used to establish a nomogram to predict the cancer-specific survival (CSS) probability of MTSCC patients. The nomogram was validated by the concordance index (C-index), the area under the receiver-operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).
Results: Following screening, 284 patients were randomized, with 199 people placed in the training cohort and 85 people placed in the validation cohort, at a ratio of 7:3. By using multivariate Cox regression analysis, it was discovered that chemotherapy, lymph node dissection, brain, bone, lung metastases, and N stage were independent risk factors for CSS. The C-index was 0.664 in the training group and 0.683 in the validation group. The AUC of 1-, 3-, and 5-year CSS rates was more than 0.71, and the calibration plot further demonstrated the nomogram's strong validity. DCA showed that the nomogram had good clinical significance.
Conclusion: The CSS probability of patients with MTSCC can be reliably and intuitively predicted by the established nomogram model.
期刊介绍:
Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, edited by leaders in the field, Professor Giovanni Lodi (Editor-in-Chief, Milan, Italy), Professor Stefano Petti (Deputy Editor, Rome, Italy) and Associate Professor Gulshan Sunavala-Dossabhoy (Deputy Editor, Shreveport, LA, USA). The journal is pre-eminent in oral medicine. Oral Diseases specifically strives to link often-isolated areas of dentistry and medicine through broad-based scholarship that includes well-designed and controlled clinical research, analytical epidemiology, and the translation of basic science in pre-clinical studies. The journal typically publishes articles relevant to many related medical specialties including especially dermatology, gastroenterology, hematology, immunology, infectious diseases, neuropsychiatry, oncology and otolaryngology. The essential requirement is that all submitted research is hypothesis-driven, with significant positive and negative results both welcomed. Equal publication emphasis is placed on etiology, pathogenesis, diagnosis, prevention and treatment.